
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical Data at Alzheimer’s Conferences
Alpha Cognition to Present New Clinical Data on ZUNVEYL® at Upcoming Alzheimer’s-Focused Conferences Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company dedicated to advancing therapies for neurodegenerative diseases, announced today that it will present…








